Swift Biosciences expands coronavirus research with ACE2 Swift Normalase Amplicon Panel
Swift Biosciences is engaged in providing next-generation sequencing assay technologies that propel genomics, translational, and clinical research
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Aug 20
Swift Biosciences is engaged in providing next-generation sequencing assay technologies that propel genomics, translational, and clinical research
18 Aug 20
The new technology will enable labs to quickly ramp up testing capacity and generate results faster
14 Aug 20
The new testing cartridge has been designed to avoid operator errors through its simplified procedure, and provide consistent…
14 Aug 20
To be tested, the user will simply obtain a drop of blood with a safety lancet and apply…
14 Aug 20
The volume of shares tendered into the offer within the acceptance period did not satisfy the minimum acceptance…
14 Aug 20
DRCG found an effective, low-cost method for the rapid diagnosis of both early marker and late marker, IgM/IgG…
13 Aug 20
Sherlock CRISPR SARS-CoV-2 test kit has been designed to programme a CRISPR molecule to detect the presence of…
13 Aug 20
Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of…
13 Aug 20
Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide
12 Aug 20
The Lumit Dx SARS-CoV-2 immunoassay can be easily adapted by most liquid handlers to boost the testing of…